| Nanodroplet processing platform for deep and quantitative proteome profiling of 10–100 mammalian cells Y Zhu, PD Piehowski, R Zhao, J Chen, Y Shen, RJ Moore, AK Shukla, ... Nature communications 9 (1), 882, 2018 | 467 | 2018 |
| Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes SJ Richardson, T Rodriguez-Calvo, IC Gerling, CE Mathews, JS Kaddis, ... Diabetologia 59 (11), 2448-2458, 2016 | 281 | 2016 |
| Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes JAB Babon, ME DeNicola, DM Blodgett, I Crèvecoeur, TS Buttrick, ... Nature medicine 22 (12), 1482-1487, 2016 | 278 | 2016 |
| Apoptotic cells induce Mer tyrosine kinase–dependent blockade of NF-κB activation in dendritic cells P Sen, MA Wallet, Z Yi, Y Huang, M Henderson, CE Mathews, HS Earp, ... Blood 109 (2), 653-660, 2007 | 262 | 2007 |
| Sepsis induces early alterations in innate immunity that impact mortality to secondary infection MJ Delano, T Thayer, S Gabrilovich, KM Kelly-Scumpia, RD Winfield, ... The Journal of Immunology 186 (1), 195-202, 2011 | 198 | 2011 |
| Sixteen diverse laboratory mouse reference genomes define strain-specific haplotypes and novel functional loci J Lilue, AG Doran, IT Fiddes, M Abrudan, J Armstrong, R Bennett, ... Nature genetics 50 (11), 1574-1583, 2018 | 189 | 2018 |
| Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes AW Michels, LG Landry, KA McDaniel, L Yu, M Campbell-Thompson, ... Diabetes 66 (3), 722-734, 2017 | 180 | 2017 |
| Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study AA Seyhan, YO Nunez Lopez, H Xie, F Yi, C Mathews, M Pasarica, ... Scientific reports 6 (1), 31479, 2016 | 174 | 2016 |
| MerTK is required for apoptotic cell–induced T cell tolerance MA Wallet, P Sen, RR Flores, Y Wang, Z Yi, Y Huang, CE Mathews, ... The Journal of experimental medicine 205 (1), 219-232, 2008 | 169 | 2008 |
| Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling MJ Delano, KM Kelly-Scumpia, TC Thayer, RD Winfield, PO Scumpia, ... The Journal of Immunology 187 (2), 911-918, 2011 | 166 | 2011 |
| Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes MJ Haller, SE Gitelman, PA Gottlieb, AW Michels, SM Rosenthal, ... The Journal of clinical investigation 125 (1), 448-455, 2015 | 164 | 2015 |
| NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity HM Tse, TC Thayer, C Steele, CM Cuda, L Morel, JD Piganelli, ... The Journal of Immunology 185 (9), 5247-5258, 2010 | 148 | 2010 |
| HLA-A* 0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes T Takaki, MP Marron, CE Mathews, ST Guttmann, R Bottino, M Trucco, ... The Journal of Immunology 176 (5), 3257-3265, 2006 | 146 | 2006 |
| The role of NOD mice in type 1 diabetes research: lessons from the past and recommendations for the future YG Chen, CE Mathews, JP Driver Frontiers in endocrinology 9, 323089, 2018 | 135 | 2018 |
| Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes TC Thayer, M Delano, C Liu, J Chen, LE Padgett, HM Tse, M Annamali, ... Diabetes 60 (8), 2144-2151, 2011 | 119 | 2011 |
| Constitutive differences in antioxidant defense status distinguish alloxan-resistant and alloxan-susceptible mice CE Mathews, EH Leiter Free Radical Biology and Medicine 27 (3-4), 449-455, 1999 | 117* | 1999 |
| New mouse model to study islet transplantation in insulin-dependent diabetes mellitus CE Mathews, SH Langley, EH Leiter Transplantation 73 (8), 1333-1336, 2002 | 114 | 2002 |
| Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy JR Lowe, DJ Perry, AKS Salama, CE Mathews, LG Moss, BA Hanks Journal for ImmunoTherapy of Cancer 4, 1-8, 2016 | 105 | 2016 |
| Use of nonobese diabetic mice to understand human type 1 diabetes TC Thayer, SB Wilson, CE Mathews Endocrinology and Metabolism Clinics 39 (3), 541-561, 2010 | 100 | 2010 |
| Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes WI Yeh, HR Seay, B Newby, AL Posgai, FB Moniz, A Michels, ... Frontiers in Immunology 8, 1313, 2017 | 91 | 2017 |
Todd BruskoProfessor, University of Florida, Department of Pathology; Diabetes Institute - Research DirectorE-mail megerősítve itt: ufl.edu
